|Bid||0.00 x 1300|
|Ask||0.00 x 800|
|Day's range||82.13 - 83.47|
|52-week range||55.36 - 90.61|
|Beta (5Y monthly)||0.80|
|PE ratio (TTM)||14.67|
|Earnings date||04 Aug 2021|
|Forward dividend & yield||2.00 (2.43%)|
|Ex-dividend date||22 Jul 2021|
|1y target est||94.90|
CVS Health's (CVS) consumer-centric digital approach to administer vaccines across the nation is expected to have strongly contributed to its Q2 performance within retail segment.
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CVS Health (CVS) closed at $82.87 in the latest trading session, marking a -0.48% move from the prior day.